Health Care-Associated MRSA Versus Community-Associated MRSA

Disease-a-Month

Volumn 54, Issue 12, 2008, Pages 763-768

  Chavez, Temujin T ^a   Decker, Catherine F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL SKIN DISEASE; EPIDEMIC; GENOTYPE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; REVIEW; STAPHYLOCOCCUS INFECTION;

COMMUNICABLE DISEASE CONTROL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; INCIDENCE; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PROGNOSIS; PUBLIC HEALTH; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 55249111507     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.09.004     Document Type: Review

References (23)

1. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40 (2005) 562-573
2. Kourbatova E.V., Halvosa J.S., King M.D., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 clone as a cause of healthcare-associated infections among patients with prosthetic joint infections. Am J Infect Control 33 (2005) 385-391
3. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 (2001) 178-182
4. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
5. Boyce J.M. Methicillin-resistant Staphylococcus aureus: detection, epidemiology, and control measures. Infect Dis Clin North Am 3 (1989) 901-913
6. Saravolatz L.D., Pohlod D.J., and Arking L.M. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 97 3 (1982) 325-329
7. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison: Mississippi, 2000. MMWR Morb Mortal Wkly Rep 50 (2001) 919-922
8. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352 (2005) 468-475
9. Maguire G., Arthur A., Boustead P., et al. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australia hospital. J Hosp Infect 38 (1998) 273-281
10. Centers for Disease Control and Prevention. Public Health Dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infection: Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 52 5 (2003) 88
11. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 48 (1999) 707-710
12. Eady E.A., and Cove J.H. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus: an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 16 (2003) 103-124
13. Carleton H.A., Diep B.A., Charlebois E.D., et al. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir for MRSA. J Infect Dis 190 (2004) 1730-1738
14. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 (2003) 131-139
15. Gorwitz R.J., Jernigan D.B., Powers J.H., et al. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention, 2006. http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html Accessed May 15, 2008
16. Doehbeling B.N., Reagan D.R., Pfadder M.A., et al. Long term efficacy of intranasal mupirocin ointment. Arch Intern Med 154 (1994) 1505-1508
17. Diederen B.M., and Kluytmans J.A. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 52 (2006) 157-168
18. Deurenberg R.H., Vink C., Kalenic S., et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 13 (2007) 222-235
19. Vandenesch F., Naimi T., Enright M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
20. King M.D., Humphrey B.J., Wang Y.F., et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as predominant cause of skin and soft-tissue infections. Ann Intern Med 144 (2006) 309-317
21. Chambers H.F. Community-associated MRSA: resistance and virulence converge. N Engl J Med 352 (2005) 1485-1487
22. Charlebois E.D., Bangsberg D.R., Moss N.J., et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 34 (2002) 425-433
23. Bradley S.F. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 26 (2005) 643-649